Supercharging A New FDA: Marty Makary on Science, Power & Patients
FDA Commissioner Dr. Marty Makary outlines a radical overhaul of the agency at the JPMorgan Healthcare Conference. By ending "medical dogma" and leveraging data, the "New FDA" aims to slash approval timelines and prioritize patient outcomes over bureaucratic process.